Workshop Day: 23rd September 2009

  • Workshop One: Co-Crystallisation with the Crystalline™, A New Bench Top Reactor for Solid State Research
  • Workshop Two: Characterisation of Co-Crystals

07.45 – 08.00 Registration and Coffee

08.00 – 08.30 Transport to Avantium Technology

Please note attendance maybe restricted. Please call for more information

08.30 – 12.30 Workshop One – Co-Crystallisation with the Crystalline™, A New Bench Top Reactor for Solid State Research

The Crystalline™ is a small scale parallel crystalliser with particle visualisation capabilities in combination with programmable temperature control and transmission analytics. The instrument operates on a milliliter scale (1-5 ml working volume) and incorporates through the vial analytics, making it possible to scan many conditions for possible habit changes, enabling rapid screening during process development. During the workshop you have the opportunity to become familiar with the capabilities of the Crystalline™. You will see how you can optimise your co-crystallisation process.

Dr Ir. J.H. Ter Horst
Intensified Reaction and Separation Systems
Delft University of Technology
Dr A. Coetzee
Director Product Development Systems
Avantium Technologies

12.30 Return to hotel Please note attendance maybe restricted. Please call for more information

13.30 – 16.00 Workshop Two: Characterisation of Co-Crystals

Whilst this is a topic which has been addressed in numerous papers and reports globally it is one essential to get right, the correct understanding and essential techniques to characterise a co-crystal are necessary for further development. Incorrect characterisation can be detrimental to the whole project, which is why we have organised a discussion forum where top tips and best practices can be shared for you to ensure you are using the most suitable techniques in the most effective way. (Including networking coffee break)

Facilitated by:

Dr Peter Kaprinski
Principal Fellow and Leader of US Salt and Polymorphism and Particle Engineering networks
Novartis